Skip navigation

Refine by Type

Results 1 - 10 of 28 for ALEMTUZUMAB
  1. Alemtuzumab injection is used to treat B-cell chronic lymphocytic leukemia (a slowly developing cancer in which ... of white blood cell accumulate in the body). Alemtuzumab is in a class of medications called monoclonal ...
  2. ... gotten better after treatment with fludarabine (Fludara) and alemtuzumab (Campath). Ofatumumab injection is in a class of ...
  3. ... or obinutuzumab PCR: pentostatin (Nipent), cyclophosphamide, and rituximab Alemtuzumab (Campath) Fludarabine (alone) Other drugs or combinations of ... For many people who have already had fludarabine, alemtuzumab seems to be helpful as second-line treatment, ...
  4. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... in their destruction. Rituximab may also induce apoptosis. Alemtuzumab (Campath®) is approved to treat patients with B- ... other cells of the immune system. Binding of alemtuzumab to CD52 triggers an immune response that destroys ...
  5. ... vomiting, hair loss, and irritation of the bladder. Alemtuzumab — Alemtuzumab is a monoclonal antibody that can be used ... surface of leukemic cells. The antigens targeted by alemtuzumab are different from those targeted by rituximab. Alemtuzumab ...
  6. ... to treat mycosis fungoides and the Sézary syndrome. Alemtuzumab and denileukin diftitox are monoclonal antibodies used to ... with pralatrexate . Targeted therapy with a monoclonal antibody ( alemtuzumab or denileukin diftitox ). A clinical trial of ultraviolet ...
  7. Treatment of Hypereosinophilic Syndrome (HES) (American Partnership for Eosinophilic Disorders)  
    ... very important protein that governs eosinophil growth, and alemtuzumab that targets the CD52 protein expressed on the ... from blood that provides signal for eosinophil growth. Alemtuzumab, on the other hand, by binding to CD52 ...
  8. Cutaneous T Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... of protein that can bind to tumor cells. Alemtuzumab (Campath®)—alemtuzumab is FDA approved to treat chronic lymphocytic leukemia ( ... g., vorinostat, romidepsin). l Monoclonal antibodies, such as alemtuzumab (Campath®), are being evaluated in SS treatment using lower ...
  9. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Fluorouracil) Afatinib Dimaleate Afinitor (Everolimus) Aldara (Imiquimod) Aldesleukin Alemtuzumab Alimta (Pemetrexed Disodium) Aloxi (Palonosetron Hydrochloride) Ambochlorin (Chlorambucil) ...
  10. Index to Drug-Specific Information (Food and Drug Administration)  
    ... fluticasone propionate; salmeterol xinafoate) Adderall (amphetamine salts) Alendronate Alemtuzumab Aleve (naproxen sodium) Alimta (pemetrexed) Aliskiren Alli (orlistat) ...
previous · 1 · 2 · 3 · next